Cargando…
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668822/ https://www.ncbi.nlm.nih.gov/pubmed/36385103 http://dx.doi.org/10.1038/s41408-022-00743-0 |
_version_ | 1784831996059451392 |
---|---|
author | Barbui, Tiziano Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Carioli, Greta Rambaldi, Alessandro Finazzi, Maria Chiara Bellini, Marta Rumi, Elisa Vanni, Daniele Borsani, Oscar Passamonti, Francesco Mora, Barbara Brociner, Marco Guglielmelli, Paola Paoli, Chiara Alvarez-Larran, Alberto Triguero, Ana Garrote, Marta Pettersson, Helna Andréasson, Björn Barosi, Giovanni Vannucchi, Alessandro Maria |
author_facet | Barbui, Tiziano Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Carioli, Greta Rambaldi, Alessandro Finazzi, Maria Chiara Bellini, Marta Rumi, Elisa Vanni, Daniele Borsani, Oscar Passamonti, Francesco Mora, Barbara Brociner, Marco Guglielmelli, Paola Paoli, Chiara Alvarez-Larran, Alberto Triguero, Ana Garrote, Marta Pettersson, Helna Andréasson, Björn Barosi, Giovanni Vannucchi, Alessandro Maria |
author_sort | Barbui, Tiziano |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9668822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96688222022-11-18 Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score Barbui, Tiziano Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Carioli, Greta Rambaldi, Alessandro Finazzi, Maria Chiara Bellini, Marta Rumi, Elisa Vanni, Daniele Borsani, Oscar Passamonti, Francesco Mora, Barbara Brociner, Marco Guglielmelli, Paola Paoli, Chiara Alvarez-Larran, Alberto Triguero, Ana Garrote, Marta Pettersson, Helna Andréasson, Björn Barosi, Giovanni Vannucchi, Alessandro Maria Blood Cancer J Correspondence Nature Publishing Group UK 2022-11-16 /pmc/articles/PMC9668822/ /pubmed/36385103 http://dx.doi.org/10.1038/s41408-022-00743-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Barbui, Tiziano Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Carioli, Greta Rambaldi, Alessandro Finazzi, Maria Chiara Bellini, Marta Rumi, Elisa Vanni, Daniele Borsani, Oscar Passamonti, Francesco Mora, Barbara Brociner, Marco Guglielmelli, Paola Paoli, Chiara Alvarez-Larran, Alberto Triguero, Ana Garrote, Marta Pettersson, Helna Andréasson, Björn Barosi, Giovanni Vannucchi, Alessandro Maria Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score |
title | Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score |
title_full | Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score |
title_fullStr | Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score |
title_full_unstemmed | Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score |
title_short | Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score |
title_sort | increased risk of thrombosis in jak2 v617f-positive patients with primary myelofibrosis and interaction of the mutation with the ipss score |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668822/ https://www.ncbi.nlm.nih.gov/pubmed/36385103 http://dx.doi.org/10.1038/s41408-022-00743-0 |
work_keys_str_mv | AT barbuitiziano increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT ghirardiarianna increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT carobbioalessandra increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT masciulliarianna increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT carioligreta increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT rambaldialessandro increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT finazzimariachiara increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT bellinimarta increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT rumielisa increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT vannidaniele increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT borsanioscar increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT passamontifrancesco increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT morabarbara increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT brocinermarco increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT guglielmellipaola increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT paolichiara increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT alvarezlarranalberto increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT trigueroana increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT garrotemarta increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT petterssonhelna increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT andreassonbjorn increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT barosigiovanni increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore AT vannucchialessandromaria increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore |